USANA Health Sciences (USNA) Tops Q4 EPS by 44c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
USANA Health Sciences Inc. (USNA) PT Raised to $126 at Roth Capital
February 10, 2021 7:12 AM ESTRoth Capital analyst David Bain raised the price target on USANA Health Sciences Inc. (NYSE: USNA) to $126.00 (from $107.00) while maintaining a Buy rating.
The analyst comments "Following a 7%/~24% revenue/EBITDA beat versus consensus, we raise our CY21/CY22 estimates and target price.... More
